Q: I heard a rumor that the antipsychotic QMs are about to go through a complete change. Is this true? A: Not entirely – but there is an important change on the horizon. In a recent memorandum, CMS announced a significant update to the long-stay...
Q: When is a Gradual Dose Reduction (GDR) required for antipsychotic and psychotropic medications in a Skilled Nursing Facility (SNF)? A: For a resident who is receiving an antipsychotic, a GDR is required unless it is clinically contraindicated. An attempt to...
Description This session will review the antipsychotics quality measures that impact the Quality Measure component of the Nursing Home Compare Five-Star Quality Rating system. During the session, we will review how these measures are calculated and how they impact...
Q: For the Quality Measure “Percent of Residents Who Newly Received an Antipsychotic Medication (SS),” is the initial assessment used in the calculation always an Admission or 5-Day? A: For this measure, the initial assessment is the first assessment completed...
Q: I understand that CMS will be conducting audits of schizophrenia coding in the MDS data and potentially adjusting the long-stay residents who are receiving antipsychotic drugs QM ratings when inaccurate coding is found. What are the criteria for diagnosing...